Home   The Company    Technology & Products    Financing    Downloads    Meet us    Chronology & News 
 
Chronology & News

  • July 2009 - PHE377 enters in Phase I Clinical studies

    Press Release PHE 377 July 09.pdf

  • September 2008 - Series B round of financing closed at 6 € Million

    PharmEste press release October 2008.pdf

  • November 2007 - PHE377 enters in development phase

  • July 2007 - Identification of the first candidate drug PHE377 for the treatment of pain

  • January 2007 - Series A round of financing closed at 3.2 € Million

  • September 2003 – Year of Foundation

    •      
     
     
    PharmEste Business Unit: Technology Park:



    Scientific-Technological Campus, Block B,
    Ground Floor:
    Via Ariosto 21- 20091 Bresso (Milan), Italy
    Tel. +39 02 66524550; Fax +39 02 66524547
    P.I. 01600600389

    Via Saragat 1 - 44100 Ferrara, Italy